Blood cancers, Myeloma, Non-Hodgkin lymphoma (NHL)
Results
Phase 1
This trial is looking at whether other drugs affect the way the body breaks down bortezomib (Velcade) in people with non Hodgkin lymphoma or myeloma that has continued to grow.
Recruitment start: 31 July 2007
Recruitment end: 18 December 2009
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Prof Simon Rule
Johnson and Johnson Pharmaceutical R+D
Last reviewed: 17 Dec 2015
CRUK internal database number: 2501
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
